Spain – Influenza vaccines – SUPPLY OF VACCINES AGAINST SEASONAL INFLUENZA, THREE LOTS (LOT 1, LOT 2 AND LOT 4) FOR THE 2026–2027 SEASONAL INFLUENZA VACCINATION CAMPAIGN IN THE COMMUNITY OF MADRID

Opportunity description

Contracts based on lots 1, 2 and 4 of Framework Agreement 202407AM0001 for the selection of suppliers of vaccines against seasonal influenza for certain contracting authorities of the General State Administration, the Cities of Ceuta and Melilla, and several autonomous communities. Inactivated vaccines produced from viruses grown in embryonated eggs, from split viruses or surface antigens (H and N), or analogous vaccines, containing 15 micrograms of hemagglutinin from each strain included in the vaccine. Inactivated vaccines produced from viruses grown in embryonated eggs, from split viruses or surface antigens (H and N), or analogous vaccines, containing 15 micrograms of hemagglutinin from each strain included in the vaccine, with adjuvant or analogous vaccines. Inactivated vaccines produced from viruses grown in cell cultures, from split viruses or surface antigens (H and N), or analogous vaccines, containing 15 micrograms of hemagglutinin from each strain included in the vaccine. Procedure: oth-single. Estimated value: 17,784,100 EUR. Review the original TED notice for the complete requirement, lots, amendments and attachments.